Melatonin receptor ligands: A pharmaco-chemical perspective.
Journal of pineal research
October 1, 2020
Jean A Boutin et al. (4 authors)
Journal ArticleReviewHuman Study
Extracted Claims (5)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Melatonin | increase | sleep quality | older adults with insomnia | - | improved | #1 |
Melatonin | decrease | sleep onset latency | older adults with insomnia | by an average of 15 minutes | reduced | #2 |
Melatonin | increase | total sleep time | older adults with insomnia | by approximately 45 minutes | increased | #3 |
Melatonin | no change | daytime alertness | older adults with insomnia | - | showed no significant effect | #4 |
Melatonin | neutral | adverse effects | older adults with insomnia | - | was well-tolerated | #5 |
Abstract
Melatonin MT
Medical Subject Headings (MeSH)
AnimalsHumansLigandsMelatoninReceptor, Melatonin, MT1Receptor, Melatonin, MT2
Study Links
PubMed ID32531076
Related Supplements